DUBLIN–(BUSINESS WIRE)–The “The Worldwide Market for In Vitro Diagnostic Tests, 15th Edition” report has been added to ResearchAndMarkets.com’s offering.
In Vitro Diagnostics (IVD) is an enormous market and having comprehensive information on the state of IVD and its future is a vital part of making well-informed decisions.
The 15th edition of The Worldwide Market for In Vitro Diagnostic Tests provides readers with reliable estimates, real-world forecasts, and insights needed to understand the IVD market in its entirety.
This 1,500+ page report is based on vendor reporting, interviews, vendor activities, and more on a global scale. The full assessment of the IVD diagnostic market makes The Worldwide Market for In Vitro Diagnostic Tests the most trusted report by top companies in the industry.
The report is a testament to the analyst’s methodology. It is the result of months of painstaking work by an experienced IVD industry analyst, who has tracked hundreds of in vitro diagnostic companies for developments, trends and financial results. This research is compiled along with the opinion, observations and insights of industry experts to produce an unparalleled vision of the in vitro diagnostics industry as it is in 2022.
The report has complete IVD market research sections with test segment estimates and forecasts in: Clinical Chemistry, Hematology, Histology, Company Profiles and Rankings, Molecular, Immunoassay, Infectious Disease, Coagulation, Blood Bank IVD, Point of Care. This is every significant segment in in vitro diagnostics.
Every significant test category in IVD is given a chapter with sub-segments. It’s like having ten market research reports in one.
The Worldwide Market for In Vitro Diagnostic Tests is the result of months of analysis and review of secondary sources by seasoned analysts, critical readings of current and historic company filings and releases, interviews with relevant experts and searching of government sources and journal literature.
All test segments contain valuable information on current market size and future projection. Compound annual growth rate is provided, as well as significant IVD companies in the market and IVD manufacturer’s product innovations. This detailed look at the IVD market yields unparalleled global market modeling.
Country-Level Coverage
The in vitro diagnostics market is a global one, and The Worldwide Market for In Vitro Diagnostic (IVD) Tests reflects the international scope of the in vitro diagnostics market size. In the healthcare market, IVD companies sell globally and think globally.
Overall IVD market size for every significant world country. Detail for major market segments, US, Japan, Europe, China.
Trends in one part of the world affect IVD manufacturers’ product decisions and company financial performance in others.
Competitive Analysis and Corporate Profiling
The report concentrates over a thousand pages on detailed and tiered profiles of companies in the in vitro diagnostics market. The experience that the analyst has in the in vitro diagnostic market is evident in its tiering and segmentation of companies.
Profiles of IVD-relevant companies. No other resource comes close.
First tier, second-tier and specialist companies are profiled. Financial results, product launches, company history and strategic plans are analyzed in the profiles. Over 200 Profiles are included in the report.
Why The Worldwide Market for In Vitro Diagnostic Tests?
Maximum Value: One Report, All Segments, World Markets
Published Since 1999, by an Expert Firm That Focuses on IVD and Related Healthcare
Profiles of 300+ Companies in the Market, Detail on the Top 40
Use the Industry-Utilized and Business Planning Numbers
Learn Who is Launching Products and Investing in the IVD Industry
Overall IVD Markets for Every Significant Nation, Detail for Major Markets
Based on Latest Financial Reporting, Real-World Industry and Medical Practice Trends
This report gives you definitive answers to important questions like:
What is the Size of IVD Market Segments?
Within Those Segments, How Do They Break Down?
Where Will Those Markets be In Five Years?
How Has the IVD Market Changed Over Time?
Who’s Winning?
Who’s Merged?
Who’s Launched Game-Changing Products?
What is the Competitive Landscape?
Who Can I Partner With?
Where are the Growth Markets I Can Enter or Buy Into?
and more…
Key Topics Covered:
Summary
Scope and Methodology
Size and Growth of the Market
IVD Market Highlights
Point of View
Significant Gains in IVD Segments Over Three Years
COVID-19 Impact and Summary
What to Watch Long-Term
Regions of Market Influence: Korea and China
Collaborations Between IVDs
New Sample Methods
PAMA on the Horizon, Particularly for POC
African Nations IVD Market
Introduction
IVD Landscape
Report Design
Changes Between 14th and 15th Editions
PAMA and CMS
Market Analysis of IVD Market Segments
Top Suppliers and Niche Players
Introduction
Overview of the Top Tier Companies
The Impact of COVID for the Top Tier Companies
IVD Companies Mergers & Acquisitions
Collaboration, Partnership, Alliance Agreements
Test Services
Historical IVD Market vs Today
In the Beginning to Now
Future
Next-Generation Sequencing
Cancer Testing (Liquid Biopsy)
Companion Diagnostics
Point of View
COVID-19 Impact and Summary
COVID-19 Market Value
The Global Picture for In Vitro Diagnostic Markets
Background
Simultaneous Threats: Chronic and Acute
Expected World IVD Market Developments
Global Population and Aging
Workforce Reduction
WHO Essential IVD List
Increase in Chronic Diseases
Emerging and Emerged Markets
Size and Forecast for the Global IVD Market
The IVD Market in the United States
PAMA and Reimbursement Changes
Impact of CARES Act on PAMA
LDT Oversight Update
Changes Resulting from COVID-19 Pandemic
Precision Medicine and NGS
IVD Market in Europe: Growing Markets
EU Regulation
Precision Medicine in Europe
Brexit
Japan
Eastern Europe: Growth Region
China: Current IVD Market
Clinical Laboratory Market in China
IVD Distribution in China
India: Population and Opportunity
Clinical Laboratory Market in India
IVD Regulation
Rest of Asia
Brazil
Disease Trends
Clinical Laboratory Market in Brazil
IVD Regulation
Mexico
The Russian Federation
Canada
Emerging Markets
Saudi Arabia IVD Market
South Africa IVD Market
South Korea IVD Market
Turkey IVD Market
United Arab Emirates (UAE) IVD Market
Other Markets to Watch
IVD Market Opportunity by Country
Company and Industry Trends
Introduction
Advanced Medicine Without Borders
China Market Information
Direct to Consumer Genetic Test Services
Future Trends
Gene Editing
CRISPR as a Diagnostic Tool
CRISPR and the Food Industry
Microbiome
Next Generation Sequencing
Liquid Biopsy
Quality Assurance
Product News
Market Cleared Products
Liquid Biopsy in Microbiology
Liquid Biopsy Companies in 2021-2022
The Future for Liquid Biopsy
Information Technology Advances and Artificial Intelligence
AI in Clinical Practice
The Regulatory Pathway
Product Initiatives
IBM Watson Health
AI in Liquid Biopsy
Future Trends
Exosome Sequencing
Biotin Interference in Immunoassay Detection Errors
Traumatic Brain Injury and IVD
Telehealth
Blockchain
Substance Abuse
Opioid Epidemic
COVID-19 and Substance Abuse
Biomarkers and Substance Abuse
Clinical Laboratory Testing for Drugs of Abuse
Urine
Blood
Oral
Hair
Micro-hospital Opportunities
Climate Change and Infectious Disease
Kickback Schemes
Early Sepsis Detection
Companies profiled include these, and many others:
Abbott Diagnostics
Accelerate Diagnostics, Inc.
Altona Diagnostics
Amoy Diagnostics Co. Ltd.
Angle
Arkray
ARUP Laboratories
Ascensia Diabetes Care Holdings AG
Beckman Coulter
Becton Dickinson (BD)
BGI Genomics (formerly Beijing Genome Institute)
Binding Site Group Ltd. (The)
Biocartis
Biocept, Inc.
Biohit
Biomerica Inc.
bioMerieux
Bio-Rad
BioReference Laboratories
Bio-Techne Corporation
Biotheranostics
Bruker
CareDx, Inc.
CellaVision AB
Cepheid
Cepheid / Danaher
Cerner Corp.
Copan
Corgenix Medical Corporation
Critical Diagnostics
Curetis
Cynvenio Biosystems (LungLife AI)
Dako A/S
Danaher
Dexcom Inc.
Diagnostica Stago, S.A.S.
DIAGON Kft. Hungary
DiaSorin
Edico Genome (Illumina)
Eiken Chemical Co. Ltd.
EKF Diagnostics Holdings PLC
ELITech Group S.A.S.
Epic Sciences
Epigenomics AG
ERBA Diagnostics, Inc.
Fujirebio
Fujirebio Diagnostics, Inc.
Genomic Health (Exact Sciences)
Greiner Bio-One International GmbH
Grifols
Guardant Health, Inc.
Hain Lifescience GmbH
Hologic
Horiba Medical
HTG Molecular Diagnostics
Human Longevity Inc.
Illumina
Immucor
Immunodiagnostic Systems (IDS)
INOVA Diagnostics, Inc.
Instrumentation Laboratory
Lab Corp
Leica Biosystems
LifeScan Inc.
Luminex Corporation
Medica Corporation
MedTest DX
Menarini Diagnostics
Meridian Bioscience, Inc.
MilliporeSigma
Mindray
Nova Biomedical
Perkin Elmer
PerkinElmer, Inc. (PE)
Qiagen
Quest
Quest Diagnostics
Quidel Ortho
Radiometer
Randox
Randox Laboratories Ltd.
Rennova Health, Inc.
Response Biomedical Corp.
Roche Diagnostics
SD Biosensor
Seegene
Sekisui Diagnostics LLC
Shimadzu Scientific Instruments
Siemens Healthineers
Singulex, Inc.
Snibe Co. Ltd.
Sonic Healthcare
Sysmex
Tecan Group
Thermo Fisher Scientific
Tosoh Bioscience
Trinity Biotech PLC
Werfen
For more information about this report visit https://www.researchandmarkets.com/r/1g7tui
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
